QA: Intelgenx Technologies Corp in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001098880_2016_Intelgenx_Technologies_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001098880, Intelgenx Technologies Corp

  xvar xval
0 AssetsCurrent 4,172,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,238,000
3 remainder_Assets 506,000
4 LiabilitiesCurrent 1,779,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 1,573,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,025,453
9 ResearchAndDevelopmentExpense 1,038,269
10 remainder_Expenses 601,518
11 remainder_Revenues 22,215,006
12 remainder_NetIncome 34,000
13 remainder_ComprehensiveNetIncome -597,608
  yvar yval
0 Assets 8,916,000
1 Liabilities 3,352,000
2 Expenses 3,665,240
3 Revenues 22,215,006
4 StockholdersEquity 5,564,000
5 NetIncome 18,583,766
6 ComprehensiveNetIncome 18,284,962
7 BaseVar 19,389,927
8 EconomicCapitalRatiobeforeLimitedLiability 4.96
9 EconomicCapitalRatio 5.16

Edgar->Model Mapping

Feature Distribution

Change over Time